PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
 
Antimicrob Agents Chemother. 2010 May; 54(5): 2269–2270.
Published online 2010 March 8. doi:  10.1128/AAC.00039-10
PMCID: PMC2863668

Identification and Characterization of CTX-M-Producing Shigella Isolates in the United States [down-pointing small open triangle]

Jason P. Folster,* Gary Pecic, Amy Krueger, and Regan Rickert
Division of Foodborne, Bacterial and Mycotic Diseases
Centers for Disease Control and Prevention
1600 Clifton Road
Atlanta, Georgia 30333
Karen Burger
Wake Forest School of Medicine
Winston-Salem, North Carolina
Alessandra Carattoli
Department of Infectious, Parasitic and Immune-Mediated Diseases
Istituto Superiore di Sanità
Rome, Italy

Shigellosis is a major source of gastroenteritis throughout the world (14). Extended-spectrum β-lactamases (ESBLs), including cefotaximases (CTX-M), confer resistance to extended-spectrum cephalosporins and significantly compromise the treatment options for shigellosis. Numerous ESBLs have been described among Enterobacteriaceae (2, 8, 13); however, only a single CTX-M-producing Shigella isolate has been reported in the United States (10).

From 1999 to 2007, 3,880 Shigella isolates were screened for antimicrobial susceptibility to 14 to 17 antimicrobials by broth microdilution (Sensititre; Trek Diagnostics, Westlake, OH). Six isolates displayed decreased susceptibility (MIC ≥ 2 mg/liter) to ceftriaxone (Table (Table1).1). The six case-patients included three males and two females (gender information was unavailable for one patient), and the median age was 3 years (range, 1 to 8 years). Additional details were available for five patients. Three of the five (60%) were hospitalized, and one was admitted twice. One patient had an adopted sibling from Russia but had not traveled herself. The second patient traveled to a neighboring state prior to illness onset, and the third reported no travel. Of the nonhospitalized patients, one was an asymptomatic adoptee from China and the second reported no travel. Two patients received antimicrobial therapy: ceftriaxone, cefotaxime, and trimethoprim-sulfamethoxazole for one patient, azithromycin for the other patient.

TABLE 1.
Characterization of CTX-M-positive Shigella isolates, transformants, and CTX-M-encoding plasmidsa

PCR analysis was used to screen the six isolates for 13 different classes or groups of bla genes, and PCR results were confirmed by DNA sequencing (1, 5, 11, 12, 16, 18-21). Four isolates were positive for the blaCTX-M-15 gene, while two were positive for the blaCTX-M-14 gene (Table (Table1).1). All four blaCTX-M-15 isolates were PCR positive for non-ESBL blaTEM-1 genes. Both blaCTX-M-14 isolates were PCR positive for non-ESBL blaOXA-1 genes, and a single isolate was positive for both blaTEM-1 and blaOXA-1. By pulsed-field gel electrophoresis (PFGE) analysis, all three S. sonnei and all three S. flexneri isolates demonstrated distinct patterns (data not shown) (15).

All six blaCTX-M genes were determined to be plasmid encoded (6). The non-ESBL β-lactamases (OXA-1, TEM-1) did not transfer and were not encoded on the same CTX-M plasmids. All three S. sonnei plasmids and two of the S. flexneri plasmids harbored only the CTX-M-associated resistance. The remaining S. flexneri plasmid contained additional determinants conferring resistance to trimethoprim-sulfamethoxazole and gentamicin.

All three S. sonnei plasmids were incompatibility type IncI1 and approximately 90 kb in size (plasmid pulsed-field gel electrophoresis) (Table (Table1)1) (4). Plasmid multilocus sequence typing (pMLST) identified them as novel sequence types designated as ST31 complex. The plasmid from AM22451 contained several point mutations in one allele, necessitating the ST32 designation within the ST31 clonal complex (http://pubmlst.org/plasmid) (7). Of the three S. flexneri plasmids, the blaCTX-M-15-positive plasmid was a 165-kb IncA/C plasmid, while the two blaCTX-M-14-positive plasmids were identical 75-kb IncFII plasmids. CTX-M-14 and CTX-M-15 are the most common types of cefotaximases identified among Shigella isolates (9, 17, 22), and IncI1 plasmids carrying CTX-M-15 have been already described in Escherichia coli and Salmonella isolates from Australia, France, and the United Kingdom (3).

The emergence of CTX-M-producing Shigella isolates in the United States is concerning and necessitates continued resistance surveillance.

Acknowledgments

We thank the NARMS participating public health laboratories for submitting the isolates, Evangeline Sowers for confirming the Shigella species, Anne Whitney for DNA sequencing, Lisa Theobald and the rest of the PulseNet team, and Rebecca Howie for their assistance.

This work was supported by an interagency agreement between the CDC and the FDA Center for Veterinary Medicine.

Footnotes

[down-pointing small open triangle]Published ahead of print on 8 March 2010.

REFERENCES

1. Bauernfeind, A., I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas. 1996. Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob. Agents Chemother. 40:509-513. [PMC free article] [PubMed]
2. Bush, K. 2008. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin. Microbiol. Infect. 14(Suppl. 1):134-143. [PubMed]
3. Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238. [PMC free article] [PubMed]
4. Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. [PubMed]
5. Chmelnitsky, I., Y. Carmeli, A. Leavitt, M. J. Schwaber, and S. Navon-Venezia. 2005. CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49:4745-4750. [PMC free article] [PubMed]
6. Folster, J. P., G. Pecic, S. Bolcen, L. Theobald, K. Hise, A. Carattoli, S. Zhao, P. F. McDermott, and J. M. Whichard. 2010. Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from humans in the United States. Foodborne Pathog. Dis. 7:181-187. [PubMed]
7. Garcia-Fernandez, A., G. Chiaretto, A. Bertini, L. Villa, D. Fortini, A. Ricci, and A. Carattoli. 2008. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. J. Antimicrob. Chemother. 61:1229-1233. [PubMed]
8. Gonzalez-Sanz, R., S. Herrera-Leon, M. de la Fuente, M. Arroyo, and M. A. Echeita. 2009. Emergence of extended-spectrum beta-lactamases and AmpC-type beta-lactamases in human Salmonella isolated in Spain from 2001 to 2005. J. Antimicrob. Chemother. 64:1181-1186. [PubMed]
9. Izumiya, H., Y. Tada, K. Ito, T. Morita-Ishihara, M. Ohnishi, J. Terajima, and H. Watanabe. 2009. Characterization of Shigella sonnei isolates from travel-associated cases in Japan. J. Med. Microbiol. 58:1486-1491. [PubMed]
10. Kim, S., J. Hu, R. Gautom, J. Kim, B. Lee, and D. S. Boyle. 2007. CTX-M extended-spectrum beta-lactamases, Washington State. Emerg. Infect. Dis. 13:513-514. [PMC free article] [PubMed]
11. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrob. Agents Chemother. 38:104-114. [PMC free article] [PubMed]
12. Ouellette, M., L. Bissonnette, and P. H. Roy. 1987. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc. Natl. Acad. Sci. U. S. A. 84:7378-7382. [PubMed]
13. Pfeifer, Y., J. Matten, and W. Rabsch. 2009. Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg. Infect. Dis. 15:1533-1535. [PMC free article] [PubMed]
14. Ram, P. K., J. A. Crump, S. K. Gupta, M. A. Miller, and E. D. Mintz. 2008. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136:577-603. [PubMed]
15. Ribot, E. M., M. A. Fair, R. Gautom, D. N. Cameron, S. B. Hunter, B. Swaminathan, and T. J. Barrett. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67. [PubMed]
16. Sabate, M., R. Tarrago, F. Navarro, E. Miro, C. Verges, J. Barbe, and G. Prats. 2000. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob. Agents Chemother. 44:1970-1973. [PMC free article] [PubMed]
17. Sabra, A. H., G. F. Araj, M. M. Kattar, R. Y. Abi-Rached, M. T. Khairallah, J. D. Klena, and G. M. Matar. 2009. Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon. J. Infect. Dev. Ctries. 3:300-305. [PubMed]
18. Schlesinger, J., S. Navon-Venezia, I. Chmelnitsky, O. Hammer-Munz, A. Leavitt, H. S. Gold, M. J. Schwaber, and Y. Carmeli. 2005. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49:1150-1156. [PMC free article] [PubMed]
19. Steward, C. D., J. K. Rasheed, S. K. Hubert, J. W. Biddle, P. M. Raney, G. J. Anderson, P. P. Williams, K. L. Brittain, A. Oliver, J. E. McGowan, Jr., and F. C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872. [PMC free article] [PubMed]
20. Vasilev, V., R. Japheth, R. Yishai, N. Andorn, L. Valinsky, S. Navon-Venezia, I. Chmelnitsky, Y. Carmeli, and D. Cohen. 2007. Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004. Eur. J. Clin. Microbiol. Infect. Dis. 26:189-194. [PubMed]
21. Winokur, P. L., D. L. Vonstein, L. J. Hoffman, E. K. Uhlenhopp, and G. V. Doern. 2001. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722. [PMC free article] [PubMed]
22. Xiong, Z., T. Li, Y. Xu, and J. Li. 2007. Detection of CTX-M-14 extended-spectrum beta-lactamase in Shigella sonnei isolates from China. J. Infect. 55:e125-e128. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)